Africa: Twice-Yearly Lenacapavir Continues to Show Strong HIV Prevention Results

[allAfrica] Twice-yearly injectable lenacapavir has continued to demonstrate exceptional protection against HIV infection.

<small>Source: AllAfrica — read the original story there.</small>